Daily non-political popular news in brief.
Mayo Clinic: Gene expression profiling not quite perfected in predicting lung cancer prognosis
11-17-2006 · EurekAlert!While there have been significant advances in the use of gene expression profiling to assess a cancer prognosis, a Mayo Clinic review and analysis of existing lung cancer studies shows that this technology has not yet surpassed the accuracy of conventional methods used to assess survival in lung cancer patients.
Read more »
Keywords: mayo, clinic, gene, expression, profiling, quite, perfected, predicting, lung, cancer, prognosis, prognosi
« Previous | Next »
Similar news on "Mayo Clinic: Gene expression profiling not quite perfected in predicting lung cancer prognosis":
- Other highlights in the Aug. 7 JNCI
08-07-2007 · EurekAlert!
Also in the Aug. 7 JNCI are a study showing vitamins and minerals do not improve liver cancer survival, another study on testicular cancer survivors' survival rates for second cancers, a gene expression pattern that predicts lung cancer prognosis and epigenetic changes in Wilms tumor.
Similar news · Read more »
- Researchers find less invasive, highly accurate methods
02-05-2008 · EurekAlert!
Using two different endoscopes together is better than using one to stage lung cancer, and is also much more precise and less invasive than the surgical method now most commonly used, researchers at Mayo Clinic in Jacksonville, Fla., report in the Feb. 6 issue of the Journal of the American Medical Association.
Similar news · Read more »
- Profiling of cancer genes may lead to better and earlier detection
12-25-2006 · EurekAlert!
A research team at UT Southwestern Medical Center has for the first time identified several genes whose expression is lost in four of the most common solid human cancers -- lung, breast, prostate and colon cancer.
Similar news · Read more »
- Mayo Clinic study shows drug could effectively treat, prevent the spread of breast cancer
11-01-2007 · EurekAlert!
A Mayo Clinic study of a drug that has shown promise in treating sarcoma, lung and brain cancers, demonstrates that the drug may also be effective in treating breast cancer, in particular the spread of breast cancer.
Similar news · Read more »
- Profiling of cancer genes may lead to better and earlier detection of solid human cancers
12-27-2006 · UT Southwestern Medical Center
A research team at UT Southwestern Medical Center has for the first time identified several genes whose expression is lost in four of the most common solid human cancers — lung, breast, prostate and colon cancer.
Similar news · Read more »
- Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
08-31-2007 · EurekAlert!
Studying the DNA of 889 people, gene hunters at the Mayo Clinic and H. Lee Moffitt Cancer Centers have identified a region on chromosome 5p that is significantly associated with dense breast tissue, a known risk factor for breast cancer. The findings are published in the September 1 issue of Cancer Research, a publication of the American Association for Cancer Research.
Similar news · Read more »
- Herceptin helps women with multiple chromosomes containing HER2 gene, study finds
12-14-2007 · EurekAlert!
The targeted therapy Herceptin helps women with HER2+ type of breast cancer independent of whether patients have extra copies of chromosome 17, home to the HER2 gene which produces the HER2 protein that fuels cancer growth. Prior to this report, there were conflicting opinions about whether that was the case, say Mayo Clinic investigators who presented their findings at the San Antonio Breast Cancer Symposium.
Similar news · Read more »
- First biomarker discovered that predicts prostate cancer outcome
08-15-2007 · EurekAlert!
Mayo Clinic researchers have identified the first immune molecule that appears to play a role in prostate cancer development and in predicting cancer recurrence and progression after surgery.
Similar news · Read more »
- Reactivating a critical gene lost in kidney cancer reduces tumor growth
08-15-2007 · EurekAlert!
Researchers at Mayo Clinic Jacksonville, have found that a key gene is often "silenced" in clear cell renal cell carcinoma, the most common type of kidney cancer, and when they restored that gene in human kidney cancer cells in culture and animal experiments, tumors stopped growing and many disappeared.
Similar news · Read more »
- Normal tissue not spared in new forms of breast cancer radiotherapy
10-30-2007 · EurekAlert!
A five-day course of radiotherapy to treat breast cancer may, in some cases, expose as much lung and heart tissue to potentially toxic radiation as does the standard six weeks of treatment, say researchers at Mayo Clinic Jacksonville.
Similar news · Read more »
